BetterLife Pharma Inc.
BetterLife Pharma Inc. (“BetterLife”) is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, BLife Therapeutics Inc., BetterLife is refining and developing drug candidates from a broad set of complementary Interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.
BetterLife Pharma Inc. (BETR)
Le 23 juin/June 2020
BetterLife Pharma Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common shares for ten (10) pre-consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 17,210,985 common shares.
The name and symbol will not change.